Mechanism of Action - The Beta Boost
Beta-agonists bind to β-adrenergic receptors, which are Gs-protein coupled. This binding initiates a signaling cascade, amplifying the initial signal.
- β1 (Heart): ↑ Inotropy, chronotropy, dromotropy, and renin release.
- β2 (Lungs/Vessels): Smooth muscle relaxation → bronchodilation & vasodilation.
⭐ Receptor location dictates the clinical effect: we have 1 heart (β1) and 2 lungs (β2).

The Agonist Lineup - Selectivity Spectrum
- Non-selective β-Agonists: Potent, but with widespread effects.
- Selective β-Agonists: Target specific receptor subtypes, minimizing off-target effects.
- β1-Selective Agonists (primarily cardiac)
- Dobutamine: ↑ Heart Rate, ↑ Contractility
- β2-Selective Agonists (primarily pulmonary/vascular smooth muscle)
- Albuterol, Salmeterol, Terbutaline: Bronchodilation
⭐ Dobutamine is a racemic mixture: the (+) isomer is a β1 agonist & α1 antagonist, while the (-) isomer is an α1 agonist. The net result is potent inotropy (β1) with minimal blood pressure change.
Clinical Applications - When to Beta-Test
- β1 Agonists (Dobutamine, Isoproterenol): Primarily for cardiac support.
- Cardiogenic Shock & Acute Decompensated HF: ↑ Inotropy & Heart Rate to boost cardiac output.
- Cardiac Stress Testing: Dobutamine mimics exercise by increasing myocardial O2 demand.
- β2 Agonists (Albuterol, Salmeterol, Terbutaline): For smooth muscle relaxation.
- Asthma/COPD: Albuterol (short-acting) for rescue; Salmeterol (long-acting) for maintenance.
- Tocolysis: Terbutaline relaxes the uterus to delay premature labor.
- Hyperkalemia: Drives K+ intracellularly, providing a temporary fix.
⭐ High-Yield: While effective for tocolysis, Terbutaline carries a Black Box Warning from the FDA against prolonged use (> 48-72 hours) due to risks of serious maternal heart problems and death.
Adverse Effects - The Beta Backfire

-
β1-Mediated (Cardiac):
- Tachycardia, palpitations, arrhythmias.
- Angina pectoris in patients with CAD (due to ↑ myocardial O₂ demand).
-
β2-Mediated (Systemic):
- Skeletal muscle tremor (most common).
- Hyperglycemia (↑ glycogenolysis).
- Hypokalemia (K⁺ driven into cells) → can worsen arrhythmias.
- Restlessness, anxiety.
⭐ Tachyphylaxis (tolerance) can develop with frequent use, particularly with Short-Acting Beta Agonists (SABAs), leading to ↓ therapeutic effect.
High‑Yield Points - ⚡ Biggest Takeaways
- Dobutamine (β1 > β2) is a key inotropic agent for acute heart failure and cardiogenic shock.
- Isoproterenol (non-selective β) causes potent increases in heart rate and contractility, but also significant vasodilation.
- Albuterol and Salmeterol (β2-selective) are primary bronchodilators for asthma/COPD; Salmeterol is long-acting.
- Terbutaline (β2-selective) is used for both bronchodilation and tocolysis (uterine relaxation).
- The core mechanism for all involves ↑ cAMP via Gs protein activation.
- Watch for tachycardia, tremor, and arrhythmias as key side effects.
Continue reading on Oncourse
Sign up for free to access the full lesson, plus unlimited questions, flashcards, AI-powered notes, and more.
CONTINUE READING — FREEor get the app